Newly tapped Senate Finance Chair Chuck Grassley (R-IA) said Wednesday (Jan. 9) he opposes Medicare drug price negotiation, but he seemed to imply he’s open to either changing or eliminating the risk corridors that help protect Part D drug plans from losing money. Drug makers, pharmacy benefit managers, and even hospitals, have been the main targets of efforts to curb rising drug prices, and Grassley’s mention of risk corridors could mean insurance companies are being pulled into the fray. Grassley...